Tech Company Financing Transactions

Ironwood Pharmaceuticals Funding Round

Morgan Stanley Expansion Capital, F-Prime Capital and Paperboy Ventures participated in a $50 million funding round for Ironwood Pharmaceuticals. The round was announced on 10/2/2008.

Transaction Overview

Company Name
Ironwood Pharmaceuticals
Announced On
10/2/2008
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors

Morgan Stanley Expansion Capital (Lead Investor)

F-Prime Capital (Stephen Knight)

Paperboy Ventures

Polaris Partners (Terry McGuire)

Ridgeback Capital

Venrock (Gur Roshwalb)

Proceeds Purpose
This infusion of equity capital will enable us to execute on our comprehensive development plans for linaclotide, which has the potential to benefit millions of patients; advance our pipeline of therapeutic candidates; and grow our sales and marketing team to commercialize our products.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Summer St. 2300
Boston, MA 02110
USA
Phone
(617) 621-7722
Website
www.ironwoodpharma.com
Email Address
[email protected]
Overview
Ironwood Pharmaceuticals (NasdaqGM: IRWD) is committed to the development of successful human medicines. Drugmaking is not a statistical event, nor simply a high-throughput industrialized pursuit.
Profile
Ironwood Pharmaceuticals LinkedIn Company Profile
Social Media
Ironwood Pharmaceuticals Company Twitter Account
Company News
Ironwood Pharmaceuticals News
Facebook
Ironwood Pharmaceuticals on Facebook
YouTube
Ironwood Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Mallon
  Mark Mallon LinkedIn Profile  Mark Mallon Twitter Account  Mark Mallon News  Mark Mallon on Facebook
Chief Financial Officer
Gina Consylman
  Gina Consylman LinkedIn Profile  Gina Consylman Twitter Account  Gina Consylman News  Gina Consylman on Facebook
Chief Medical Officer
Michael Shetzline
  Michael Shetzline LinkedIn Profile  Michael Shetzline Twitter Account  Michael Shetzline News  Michael Shetzline on Facebook
President
Thomas McCourt
  Thomas McCourt LinkedIn Profile  Thomas McCourt Twitter Account  Thomas McCourt News  Thomas McCourt on Facebook
VP - Operations
Jason Rickard
  Jason Rickard LinkedIn Profile  Jason Rickard Twitter Account  Jason Rickard News  Jason Rickard on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/2/2008: ChemoCentryx venture capital transaction
Next: 10/2/2008: Ausra venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.